Please provide your email address to receive an email when new articles are posted on . Researchers linked higher frequency of intravitreal anti-VEGF injections with a greater risk for mild cognitive ...
Wet age-related macular degeneration (AMD) is an eye condition that threatens the middle of your eyesight. It’s caused when abnormal blood vessels in your eyes leak fluid, damaging the part of your ...
Faricimab, an experimental drug, could reduce the number of injections needed to treat both age-related macular degeneration (AMD) and diabetic macular edema (DME), phase 3 trials suggest. Faricimab's ...
Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results